[go: up one dir, main page]

GB202306258D0 - New medical uses - Google Patents

New medical uses

Info

Publication number
GB202306258D0
GB202306258D0 GBGB2306258.1A GB202306258A GB202306258D0 GB 202306258 D0 GB202306258 D0 GB 202306258D0 GB 202306258 A GB202306258 A GB 202306258A GB 202306258 D0 GB202306258 D0 GB 202306258D0
Authority
GB
United Kingdom
Prior art keywords
new medical
medical uses
new
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2306258.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Attgeno AB
Original Assignee
Attgeno AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Attgeno AB filed Critical Attgeno AB
Priority to GBGB2306258.1A priority Critical patent/GB202306258D0/en
Publication of GB202306258D0 publication Critical patent/GB202306258D0/en
Priority to CN202480040298.0A priority patent/CN121311224A/en
Priority to AU2024260728A priority patent/AU2024260728A1/en
Priority to PCT/EP2024/061806 priority patent/WO2024223950A1/en
Priority to IL324187A priority patent/IL324187A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB2306258.1A 2023-04-27 2023-04-27 New medical uses Ceased GB202306258D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB2306258.1A GB202306258D0 (en) 2023-04-27 2023-04-27 New medical uses
CN202480040298.0A CN121311224A (en) 2023-04-27 2024-04-29 Mono-and di-nitrosylated propylene glycol for the treatment of thromboembolic disorders
AU2024260728A AU2024260728A1 (en) 2023-04-27 2024-04-29 Mono- and bis-nitrosylated propanediols for use in the treatment of a thromboembolic disease
PCT/EP2024/061806 WO2024223950A1 (en) 2023-04-27 2024-04-29 Mono- and bis-nitrosylated propanediols for use in the treatment of a thromboembolic disease
IL324187A IL324187A (en) 2023-04-27 2025-10-23 Propanediols with single and double nitro group transformation for use in the treatment of thromboembolic disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2306258.1A GB202306258D0 (en) 2023-04-27 2023-04-27 New medical uses

Publications (1)

Publication Number Publication Date
GB202306258D0 true GB202306258D0 (en) 2023-06-14

Family

ID=86692015

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2306258.1A Ceased GB202306258D0 (en) 2023-04-27 2023-04-27 New medical uses

Country Status (5)

Country Link
CN (1) CN121311224A (en)
AU (1) AU2024260728A1 (en)
GB (1) GB202306258D0 (en)
IL (1) IL324187A (en)
WO (1) WO2024223950A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0402221D0 (en) 2004-09-14 2004-09-14 Aerocrine Ab Treatment of insufficient perfusion
ATE534618T1 (en) 2006-03-14 2011-12-15 Lars E Gustafsson NEW METHOD FOR PRODUCING THERAPEUTIC COMPOUNDS AND COMPOSITIONS, COMPOUNDS AND COMPOSITIONS PRODUCED THEREFROM AND THE USE THEREOF
GB2579240B (en) 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
GB202007929D0 (en) 2020-05-27 2020-07-08 Attgeno Ab New medical uses
GB202007928D0 (en) 2020-05-27 2020-07-08 Attgeno Ab New uses and methods

Also Published As

Publication number Publication date
IL324187A (en) 2025-12-01
AU2024260728A1 (en) 2025-12-11
WO2024223950A1 (en) 2024-10-31
CN121311224A (en) 2026-01-09

Similar Documents

Publication Publication Date Title
GB2638927B (en) Patient interface
GB202007929D0 (en) New medical uses
GB202302225D0 (en) New medical uses
GB202205895D0 (en) New medical uses
ZAA202201461S (en) Medical devices
GB202312653D0 (en) New medical uses
GB202306258D0 (en) New medical uses
GB202303229D0 (en) New medical uses
GB202303232D0 (en) New medical uses
GB202302194D0 (en) New medical uses
GB202300857D0 (en) New medical uses
GB202212071D0 (en) New medical uses
GB202205900D0 (en) New medical uses
GB202111911D0 (en) New medical uses
GB202314100D0 (en) New medical use
GB202302278D0 (en) New medical use
GB202013014D0 (en) New medical uses
GB202219368D0 (en) New medical use
GB202217810D0 (en) Medical use
GB202216910D0 (en) Medical use
GB202509980D0 (en) New medical uses
CA225227S (en) Patient interface
GB202501574D0 (en) New medical uses
GB202410820D0 (en) New medical uses
GB202407432D0 (en) New medical uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)